This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Sanofi. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Martin Brockelmann: Innovator in Pharmaceutical Chemistry
Introduction
Martin Brockelmann is a notable inventor based in Frankfurt, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on crystalline forms of specific compounds. His expertise and dedication to research have led to advancements that benefit the pharmaceutical industry.
Latest Patents
Martin Brockelmann holds a patent for his invention titled "Crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1H-indole-5-carboxylic acid [(S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide." This invention relates to polymorphs and hydrates of the compound, processes for their preparation, and their use in pharmaceutical compositions. His work in this area has the potential to enhance the effectiveness of medications.
Career Highlights
Brockelmann is currently associated with Sanofi, a leading global healthcare company. His role at Sanofi allows him to collaborate with other experts in the field and contribute to the development of innovative pharmaceutical solutions. His patent portfolio reflects his commitment to advancing medical science.
Collaborations
Throughout his career, Martin has worked alongside talented colleagues, including Mandy Mohnicke and Guenter Billen. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Martin Brockelmann's contributions to pharmaceutical chemistry exemplify the impact of dedicated inventors in the industry. His innovative patent and collaborations highlight the importance of teamwork in advancing healthcare solutions.